Dun & Bradstreet Holdings Inc. appears in company news about business decisioning data and analytics, including Data Cloud products, sales and marketing intelligence, finance and risk solutions, and integrations that place global business data inside customer workflows. Recurring developments include product launches such as healthcare-focused datasets, partnerships for private-company deal sourcing and investigative software, and scheduled financial-results communications.
Corporate-status developments also include the company's completed 2025 merger, after which Dun & Bradstreet survived as a wholly owned subsidiary of an affiliate of investment funds managed by Clearlake Capital Group L.P.
Dun & Bradstreet (DNB) has made its D&B Commercial Graph available in the IBM watsonx Orchestrate Agent Catalog via a Model Context Protocol (MCP) server.
The integration provides AI agents with secure, standardized access to verified business identity, relationships, and commercial context, anchored by the D-U-N-S Number. This shared identity layer is designed to help enterprises move AI from prototypes to production across workflows in sales, marketing, procurement, compliance, finance, credit evaluation, and master data management.
On September 16, 2026, Dun & Bradstreet (DNB) launched Model Context Protocol integrations that connect its D&B Commercial Graph to Microsoft Copilot Studio and Dynamics 365 Sales agents.
Organizations can now build or enrich AI agents in Microsoft environments using D&B’s verified business identity, relationship, and risk data, anchored by the D‑U‑N‑S Number, to support workflows in finance and credit, compliance, sales and marketing, and master data management.
Dun & Bradstreet (DNB) released Q3 2026 results from its global AI Momentum Survey of 10,000 businesses across 32 countries, showing that over three-quarters of enterprises report measurable ROI from AI, but only 6% say their data is fully ready to support AI at scale.
The survey finds 48% see “pockets of ROI” and 28% report “broad” or “strong” ROI across multiple projects. About 34% are scaling AI into production, yet most describe their data as only partially or mostly ready, highlighting a significant data readiness gap for enterprise-wide, repeatable AI returns.
Dun & Bradstreet (NYSE:DNB) introduced a Model Context Protocol integration that brings its verified business data and risk intelligence directly into Claude for insurers.
The solution lets carriers and brokers compress commercial underwriting workflows from weeks or days to minutes, automating clearance, screening, risk profiling, and documentation while preserving governance and auditability.
Dun & Bradstreet (NYSE:DNB) is delivering agentic credit and portfolio management workflows on the Databricks Marketplace and via Databricks OpenSharing, powered by the D&B Commercial Graph and D-U-N-S Number.
In one anonymized portfolio, bad capture rate improved from 30% to about 38%, avoiding over $6 million in bad debt.
Dun & Bradstreet (NYSE:DNB) announced the Graph Connector for Microsoft 365 Copilot, offering developers and enterprises no-cost access to a curated sample of verified business data from the D&B Commercial Graph. The connector supports AI-powered workflows across sales, marketing, research, and supplier or partner discovery.
WEX (NYSE: C) and Impactive Capital reached a cooperation agreement to present a refreshed slate of 11 director nominees for the 2026 Annual Meeting, including three new independent directors: Kurt Adams, Ellen Alemany, and Lauren Taylor Wolfe. The Annual Meeting is rescheduled to May 14, 2026.
The company will separate the roles of Chair and CEO after the meeting; Melissa Smith will remain CEO and president. Impactive withdrew its separate nomination and agreed to support the revised slate; customary standstill, non-disparagement, and voting commitments apply.
Scale Asia Ventures (DNB) earned two finalist nominations at the Private Equity Wire® US Awards 2025: Performance of the Year: Venture Capital (Under $500 million) for SAV Fund I and Capital Raise of the Year: Co-invest for SAV Fund II. Winners are scheduled to be announced on November 6, 2025 in New York City.
The firm highlights an AI "barbell" strategy, late-stage portfolio companies including VAST (funding talks at ~$30 billion valuation) and Crusoe (raised ~US$1.4 billion), plus multiple exits from 2021–2025 that the firm says underpin its institutional LP traction and co-invest platform.
Scale Asia Ventures (SAV) founding Managing Partner Wally Wang has been recognized on Business Insider's 2025 Seed 100 list, ranking #95 among top early-stage investors. The recognition highlights SAV's successful AI-focused investment strategy, particularly in enterprise software companies bridging Silicon Valley innovation with Asian markets.
Wang's notable investments include Weaviate, Argilla, Array, CAST AI, Fiddler AI, and AppZen. SAV's portfolio spans both AI infrastructure companies like Mastra and Tiny Fish, and vertical AI applications such as Solve Intelligence and HiggsField AI. The firm specializes in connecting portfolio companies with strategic customers across the U.S. and Asia, providing support in go-to-market strategies, hiring, and capital access.
Dun & Bradstreet (NYSE:DNB) has launched D&B Healthcare Insights, a comprehensive healthcare dataset designed to enhance sales and marketing intelligence for companies targeting the healthcare sector. The new solution, available as an add-on to D&B Hoovers, provides detailed information about healthcare organizations (HCOs) and healthcare providers (HCPs).
The platform combines D&B Hoovers' extensive database of over 320M companies and 485M contacts with healthcare-specific data covering more than 260,000 healthcare organizations. Users can access detailed information including facility profiles, operating room size, bed counts, procedure volumes, staffing numbers, and total visits. This healthcare dataset is the first in a series of new data offerings planned by Dun & Bradstreet for 2025.
[ "Launch of comprehensive healthcare-specific dataset expanding DNB's market reach", "Access to extensive database covering 260,000+ healthcare organizations", "Integration with existing D&B Hoovers platform enhancing product offering", "First in a series of new planned data offerings indicating growth strategy" ]